Zerion APS

ZERION has is a pharmaceutical development company established as a spinout form the University of Copenhagen in 2019. ZERION has pioneered the Dispersome® technology that is addressing one of the most challenging problems in pharmaceutical development: poor solubility of small molecule drugs. By formulating insoluble small molecule APIs with novel protein-based excipients into amorphous dispersions, dramatic increases in solubility and corresponding bioavailability are achievable.

 

Contact name:

Ole Wiborg

Address:

Blokken 11, 3460 Birkerød

Telephone:

40968018

Established:

2019

Number of employees:

3

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2019 Danskbiotek. All rights reserved.